CY1107603T1 - Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης - Google Patents

Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης

Info

Publication number
CY1107603T1
CY1107603T1 CY20071100021T CY071100021T CY1107603T1 CY 1107603 T1 CY1107603 T1 CY 1107603T1 CY 20071100021 T CY20071100021 T CY 20071100021T CY 071100021 T CY071100021 T CY 071100021T CY 1107603 T1 CY1107603 T1 CY 1107603T1
Authority
CY
Cyprus
Prior art keywords
hematopoietic
growth hormone
thepapeies
myelovlastikes
epanametangisis
Prior art date
Application number
CY20071100021T
Other languages
Greek (el)
English (en)
Inventor
Alessandro Massimo Gianni
Original Assignee
Laboratoires Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono Sa filed Critical Laboratoires Serono Sa
Publication of CY1107603T1 publication Critical patent/CY1107603T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY20071100021T 1998-12-30 2007-01-08 Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης CY1107603T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
EP99965579A EP1140149B1 (en) 1998-12-30 1999-12-30 Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment

Publications (1)

Publication Number Publication Date
CY1107603T1 true CY1107603T1 (el) 2013-03-13

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100021T CY1107603T1 (el) 1998-12-30 2007-01-08 Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης

Country Status (15)

Country Link
US (1) US20060029581A1 (cg-RX-API-DMAC7.html)
EP (3) EP1016413A1 (cg-RX-API-DMAC7.html)
JP (1) JP4808316B2 (cg-RX-API-DMAC7.html)
AT (1) ATE342064T1 (cg-RX-API-DMAC7.html)
AU (2) AU772222B2 (cg-RX-API-DMAC7.html)
BR (1) BR9916726A (cg-RX-API-DMAC7.html)
CA (1) CA2354194A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107603T1 (cg-RX-API-DMAC7.html)
DE (1) DE69933581T2 (cg-RX-API-DMAC7.html)
DK (1) DK1140149T3 (cg-RX-API-DMAC7.html)
ES (1) ES2275359T3 (cg-RX-API-DMAC7.html)
IL (2) IL143994A0 (cg-RX-API-DMAC7.html)
PT (1) PT1140149E (cg-RX-API-DMAC7.html)
SI (1) SI1140149T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000040260A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム リサーチ ディベロップメント カンパニー 胚性細胞の定方向分化
CN102302493B (zh) 2001-07-31 2015-08-12 健赞股份有限公司 活化祖细胞/干细胞的方法
WO2005032572A2 (en) 2003-10-03 2005-04-14 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
BRPI0519170A8 (pt) * 2004-12-22 2018-05-08 Ambrx Inc formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
JP2013515081A (ja) * 2009-12-21 2013-05-02 アンブルックス,インコーポレイテッド 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
JPH08511263A (ja) * 1993-06-15 1996-11-26 ブリテッシュ バイオテック ファーマシューティカルズ リミテッド 造血細胞の放出と可動化
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
DE69433967D1 (de) * 1993-10-06 2004-09-30 Univ Florida Stammzellen-proliferations-faktor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
CA2227241C (en) * 1995-07-21 2004-12-21 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
EP1016414B1 (en) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
DE60140051D1 (de) * 2000-06-07 2009-11-12 Merck Serono Sa Coinsins Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
EP1779865A1 (en) 2007-05-02
IL143994A (en) 2009-06-15
DE69933581D1 (de) 2006-11-23
AU2103900A (en) 2000-07-24
EP1140149A1 (en) 2001-10-10
BR9916726A (pt) 2001-09-11
WO2000040260A1 (en) 2000-07-13
SI1140149T1 (sl) 2007-02-28
DK1140149T3 (da) 2007-02-19
JP4808316B2 (ja) 2011-11-02
AU772222B2 (en) 2004-04-22
US20060029581A1 (en) 2006-02-09
DE69933581T2 (de) 2007-06-21
AU2004203355B2 (en) 2007-05-17
CA2354194A1 (en) 2000-07-13
AU2004203355A1 (en) 2004-08-19
JP2002534393A (ja) 2002-10-15
PT1140149E (pt) 2007-01-31
IL143994A0 (en) 2002-04-21
ES2275359T3 (es) 2007-06-01
EP1016413A1 (en) 2000-07-05
ATE342064T1 (de) 2006-11-15
EP1140149B1 (en) 2006-10-11

Similar Documents

Publication Publication Date Title
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
ES2151921T3 (es) Analogo de dolastatina.
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
ATE286118T1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
MX9705710A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
BRPI0413002A (pt) genes de ciclo de célula de planta e métodos de uso
TR200001228T2 (tr) T yardımcı hücre tür 2 kökenli bağışıklık hastalıklarının retinoit antagonistlerle tedavisi
DK240088D0 (da) Fremgangsmaade til transformation af et plantecellematerale
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
DE69916807D1 (de) Kostimulatorische blockade und gemischter chimerismus in allotransplantationen
EP2278022A3 (en) Expression vectors, transfection systems, and method of use thereof
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
DK0885229T3 (da) Kondenserede pyrrolo[2,3-c]carbazol-6-oner, der potenserer aktivitet af gamma-interferon
FR2662698B1 (cg-RX-API-DMAC7.html)
FR2749022B1 (fr) Cellules aviaires immortelles
IT8120393A0 (it) Mutanti batterici, procedimento per produrli e vaccini vivi che licontengono.
BR9916726A (pt) HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes
ATE226087T1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
DE69737455D1 (de) Definierte systeme zur kultivieurng epithelialer zellen und anwendung derselben
DK0793503T3 (da) Anvendelse af hepatocyt-vækstfaktor til inducering af profilerering og differentiering af hemotopoietiske celler
YU63291A (sh) Hibridni kalcitonin
EP0765398A4 (en) POPULATION OF CELLS ENRICHED IN MYELOID AND / OR LYMPHOID PRECURSORS, PROCESSES FOR OBTAINING AND USING THE SAME
ATE278461T1 (de) Mikropartikel hergestellt aus cycloolefincopolymeren und deren verwendung zur kontrollierten wirkstofffreigabe
IL110585A0 (en) Tripeptides, their preparation and pharmaceutical compositions containing them
ATE311886T1 (de) Verwendung einer zusammensetzung enthaltend 5- androsten-3beta,17alpha-diol